Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × GIST × avapritinib × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Stromal Tumors 6 Mastocytosis, Systemic 4 Recurrence 3 Leukemia, Mast-Cell 2 Glioma 2 Neoplasms 1 Mastocytosis 1 Glioblastoma 1 GIST 1 Central Nervous System Neoplasms 1

Interventions

olverembatinib 1 avapritinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03862885 2020-07-27

Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST

Blueprint Medicines Corporation

Approved for marketing

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡